Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-059479
Filing Date
2026-02-19
Accepted
2026-02-19 16:25:39
Documents
21

Document Format Files

Seq Description Document Type Size
1 S-3 engn-20260219.htm S-3 455960
2 EX-4.1 engn-ex4_1.htm EX-4.1 1054946
3 EX-5.1 engn-ex5_1.htm EX-5.1 38161
4 EX-5.2 engn-ex5_2.htm EX-5.2 23113
5 EX-23.1 engn-ex23_1.htm EX-23.1 3932
6 EX-FILING FEES engn_exfilingfees.htm   iXBRL EX-FILING FEES 153254
7 GRAPHIC img93391562_0.jpg GRAPHIC 6156
8 GRAPHIC img93391562_1.jpg GRAPHIC 47421
9 GRAPHIC img93391562_2.jpg GRAPHIC 47421
10 GRAPHIC img94315083_0.jpg GRAPHIC 8155
11 GRAPHIC img263254780_0.jpg GRAPHIC 7738
  Complete submission text file 0001193125-26-059479.txt   2084292

Data Files

Seq Description Document Type Size
23 EXTRACTED XBRL INSTANCE DOCUMENT engn_exfilingfees_htm.xml XML 26058
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: S-3 | Act: 33 | File No.: 333-293597 | Film No.: 26654825
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)